What is the typical price for Fenofibrate 200 mg?
The price of Fenofibrate 200 mg can vary depending on the manufacturer, dosage form (e.g., capsules, tablets), and the pharmacy where it is purchased. Generally, generic versions are more affordable than brand-name drugs.
How does Fenofibrate 200 mg pricing compare across different pharmacies?
Prices for Fenofibrate 200 mg can differ significantly between major retail pharmacies, independent pharmacies, and online sources. Comparing prices across these platforms can lead to cost savings. Websites like DrugPatentWatch.com may offer insights into generic drug pricing trends [1].
When does the patent for Fenofibrate expire?
Fenofibrate, as a drug, has been available for a considerable time, and its original patents have long expired, allowing for the widespread availability of generic versions [2].
Are there different types of Fenofibrate available?
Yes, Fenofibrate is available in various formulations and strengths. Common strengths include 200 mg and 300 mg. Different formulations may offer varying absorption rates and therapeutic profiles.
Who manufactures generic Fenofibrate 200 mg?
Numerous pharmaceutical companies manufacture generic Fenofibrate 200 mg. These include companies like Teva Pharmaceuticals, Aurobindo Pharma, and Mylan N.V. (now Viatris), among others [3].
What is Fenofibrate used to treat?
Fenofibrate is a medication used to treat high cholesterol and triglyceride levels in the blood. It belongs to a class of drugs called fibrates, which work by lowering levels of triglycerides and increasing levels of HDL (good cholesterol) [4].
What are the potential side effects of Fenofibrate?
Common side effects of Fenofibrate can include gastrointestinal issues such as nausea, vomiting, and diarrhea, as well as headache, dizziness, and back pain. More serious side effects, though less common, can involve liver problems, muscle pain, and pancreatitis [4].
How does Fenofibrate work to lower cholesterol?
Fenofibrate works by activating peroxisome proliferator-activated receptors (PPARs) in the body. This activation influences genes involved in lipid metabolism, leading to a decrease in triglyceride production and an increase in HDL cholesterol levels [4].
What alternatives are there to Fenofibrate for managing cholesterol?
Other classes of cholesterol-lowering medications include statins (like atorvastatin and simvastatin), PCSK9 inhibitors, bile acid sequestrants, and ezetimibe. The choice of medication depends on the specific lipid profile and the patient's medical history [4].
Can Fenofibrate be taken with other medications?
Fenofibrate can interact with certain other medications, including blood thinners like warfarin, other cholesterol-lowering drugs (like statins, though specific combinations are sometimes prescribed under close monitoring), and certain diabetes medications. It is crucial to inform a healthcare provider about all medications and supplements being taken [4].
What clinical data supports the use of Fenofibrate?
Clinical trials have demonstrated Fenofibrate's efficacy in reducing cardiovascular events in certain patient populations, particularly those with high triglyceride levels and low HDL cholesterol [5].
What is the difference between Fenofibrate and other fibrates?
While all fibrates work by modulating lipid metabolism through PPAR activation, they differ in their chemical structure, potency, and pharmacokinetic profiles. Fenofibrate is one of the most commonly prescribed fibrates [4].
Where can I find more information on Fenofibrate patents and pricing?
Detailed information on drug patents, including expiry dates and potential market exclusivity, can be found on specialized resources like DrugPatentWatch.com [1].
---
Sources:
1. DrugPatentWatch.com
2. DrugPatentWatch.com (general knowledge base on drug patents)
3. DrugPatentWatch.com (generic manufacturer listings)
4. National Institutes of Health. (n.d.). Fenofibrate. MedlinePlus.
5. National Institutes of Health. (n.d.). Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial. ClinicalTrials.gov.